Teva Pharmaceuticals moving HQ to New Jersey – Daily Local
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
GSK's $235 million verdict revived against Teva, again | Reuters
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical's US Arm Charged With Price-Fixing
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva Pharmaceuticals moving HQ to New Jersey – Daily Local
Teva, one of the biggest generic makers, joins the the brand-name club
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
Teva Pharmaceuticals - Wikipedia
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Spurred by tax credits, Teva considers move to Parsippany - NJBIZ
Teva Pharmaceutical Industries Ltd. is moving its North American headquarters from North Wales, Mo… | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical
U.S. charges Teva in generic drugs price-fixing probe
Teva's picked an address in Parsippany, New Jersey, and the dirt's about to fly | Fierce Pharma
$40 million incentive lures global pharmaceutical giant to Parsippany
U.S. approval of Teva drug could help reverse company's migraines - The Jerusalem Post
Teva's (NYSE: TEVA) move of North American HQ to N.J. takes another step forward - Philadelphia Business Journal
Teva Pharmaceutical | P3 Properties | NJ Office Market
Teva to pay Arkansas $931K to settle price-fixing allegations (NYSE:TEVA) | Seeking Alpha
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceutical gains 6.5% following Florida opioid settlement (NYSE: TEVA) | Seeking Alpha
